XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE LIABILITIES (Tables)
9 Months Ended
Dec. 31, 2023
Debt Instrument [Line Items]  
SCHEDULE OF DERIVATIVE LIABILITIES

   2023   2022 
   $   $ 
Derivative liabilities, beginning of period   759,065    352,402 
Derivative liabilities recognized pursuant to issuance of Series B preferred shares (Note 9)   642,417     
Change in fair value of derivatives during period   (142,830)   442,309 
Reduction due to preferred shares converted   (119,359)   (53,036)
Derivative liabilities, end of period   1,139,293    741,675 
SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The lattice methodology was used to value the derivative components, using the following assumptions during the nine months ended December 31, 2023 and 2022:

   2023   2022 
Dividend yield (%)   12    12 
Risk-free rate for term (%)   4.713.7    2.14.4 
Volatility (%)   71.9119.1    85.4102 
Remaining terms (Years)   0.252.01    1 3.01 
Stock price ($ per share)   0.643.82    0.4510.62 
Convertible Debt [Member]  
Debt Instrument [Line Items]  
SCHEDULE OF DERIVATIVE LIABILITIES

   2023   2022 
   $   $ 
         
Balance beginning of period – March 31   1,008,216    520,747 
New Issuance   1,224,933     
Conversion to common shares   (39,089)   (192,794)
Change in fair value of derivative liabilities   386,845    27,662 
End of derivative treatment   (1,652,572)   (17,979)
Convertible note modification       (53,402)
Balance end of period – December 31   928,333    351,719 
SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS

The Monte-Carlo methodology was used to value the convertible note and warrant derivative components during the six months ended December 31, 2023 and 2022, using the following assumptions:

    2023    2022 
Risk-free rate for term (%)   4.25.3     4.44.4  
Volatility (%)   76.2126.6     94102  
Remaining terms (Years)   0.251.49     11  
Stock price ($ per share)   0.463.04     0.450.45